Wikidata entity: Q58397
C₂₀H₂₃N (P274)
Quantities
| P4250 | defined daily dose | 75 |
| P2067 | mass | 277.183 |
| P3780 | active ingredient in | ... | Q47521532 (Elavil) | Elavil |
| P233 | canonical SMILES | String | CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31 | ??? |
| P373 | Commons category | String | Amitriptyline | ??? |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Amitriptyline-from-picrate-xtal-3D-vdW.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q133823 (migraine) | migraine |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q540571 (fibromyalgia) | fibromyalgia |
| P2175 | medical condition treated | ... | Q1869874 (insomnia) | insomnia |
| P2175 | medical condition treated | ... | Q19000444 (neurotic disorder) | neurotic disorder |
| P129 | physically interacts with | ... | Q309513 (Histamine receptor H1) | Histamine receptor H1 |
| P129 | physically interacts with | ... | Q410142 (solute carrier family 6 member 4) | solute carrier family 6 member 4 |
| P129 | physically interacts with | ... | Q2844056 (Cholinergic receptor muscarinic 3) | Cholinergic receptor muscarinic 3 |
| P129 | physically interacts with | ... | Q4847900 (Cholinergic receptor muscarinic 1) | Cholinergic receptor muscarinic 1 |
| P129 | physically interacts with | ... | Q4847907 (Cholinergic receptor muscarinic 4) | Cholinergic receptor muscarinic 4 |
| P129 | physically interacts with | ... | Q4847910 (Cholinergic receptor muscarinic 2) | Cholinergic receptor muscarinic 2 |
| P129 | physically interacts with | ... | Q7050954 (Solute carrier family 6 member 2) | Solute carrier family 6 member 2 |
| P129 | physically interacts with | ... | Q12746120 (Cholinergic receptor muscarinic 5) | Cholinergic receptor muscarinic 5 |
| P129 | physically interacts with | ... | Q21109363 (5-hydroxytryptamine receptor 6) | 5-hydroxytryptamine receptor 6 |
| P129 | physically interacts with | ... | Q21497878 (Potassium inwardly-rectifying channel, subfamily J, member 6) | Potassium inwardly-rectifying channel, subfamily J, member 6 |
| P129 | physically interacts with | ... | Q21497881 (Potassium inwardly-rectifying channel, subfamily J, member 5) | Potassium inwardly-rectifying channel, subfamily J, member 5 |
| P129 | physically interacts with | ... | Q21497939 (5-hydroxytryptamine (serotonin) receptor 7) | 5-hydroxytryptamine (serotonin) receptor 7 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q432083 (intramuscular injection) | intramuscular injection |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P769 | significant drug interaction | ... | Q568 (lithium) | lithium |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q132621 (epinephrine) | epinephrine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q186242 (norepinephrine) | norepinephrine |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q402633 ((±)-deprenyl) | (±)-deprenyl |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q409595 (isocarboxazid) | isocarboxazid |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q412443 (risperidone) | risperidone |
| P769 | significant drug interaction | ... | Q411188 (aripiprazole) | aripiprazole |
| P769 | significant drug interaction | ... | Q412621 (methyldopa) | methyldopa |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q413717 ((RS)-baclofen) | (RS)-baclofen |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q418656 (procarbazine) | procarbazine |
| P769 | significant drug interaction | ... | Q421934 (moclobemide) | moclobemide |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q422970 ((±)-promethazine) | (±)-promethazine |
| P769 | significant drug interaction | ... | Q423292 (paliperidone) | paliperidone |
| P769 | significant drug interaction | ... | Q423364 (propranolol) | propranolol |
| P769 | significant drug interaction | ... | Q423498 (trimipramine) | trimipramine |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q599052 ((RS)-nefopam) | (RS)-nefopam |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420133 (chlorpheniramine) | chlorpheniramine |
| P769 | significant drug interaction | ... | Q420885 (tranylcypromine) | tranylcypromine |
| P769 | significant drug interaction | ... | Q834280 (bupropion) | bupropion |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q1747559 (phenelzine) | phenelzine |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q5613599 (guanfacine) | guanfacine |
| P769 | significant drug interaction | ... | Q71704041 ((E/Z)-doxepin) | (E/Z)-doxepin |
| P279 | subclass of | ... | Q76722904 (dibenzocycloheptene) | dibenzocycloheptene |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q334477 (selective serotonin reuptake inhibitor) | selective serotonin reuptake inhibitor |
| P2868 | subject has role | ... | Q899668 (adrenergic uptake inhibitors) | adrenergic uptake inhibitors |
| P2868 | subject has role | ... | Q1747785 (non-opioid analgesic) | non-opioid analgesic |
| P2868 | subject has role | ... | Q908843 (tricyclic antidepressant) | tricyclic antidepressant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | amitriptyline | ??? |
Why not click here or view trends?
log id: 1851810